Apollo Endosurgery Inc EV/EBIT
Was ist das EV/EBIT von Apollo Endosurgery Inc?
EV/EBIT von Apollo Endosurgery Inc ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apollo Endosurgery Inc
Was macht Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Unternehmen mit ev/ebit ähnlich Apollo Endosurgery Inc
- Enochian Biosciences hat EV/EBIT von N/A
- Enochian Biosciences hat EV/EBIT von N/A
- Enochian Biosciences hat EV/EBIT von N/A
- Enochian Biosciences hat EV/EBIT von N/A
- Ocean Power Technologies hat EV/EBIT von N/A
- Air France-KLM SA hat EV/EBIT von N/A
- Apollo Endosurgery Inc hat EV/EBIT von N/A
- Logica Ventures hat EV/EBIT von N/A
- Spice Mobility hat EV/EBIT von N/A
- eHealth Inc hat EV/EBIT von N/A
- Epizyme Inc hat EV/EBIT von N/A
- Nicox SA hat EV/EBIT von N/A
- VOXX International Corp hat EV/EBIT von N/A